title: Comparison of human bone marrow mononuclear cell isolation methods for creating tissue-engineered vascular grafts: novel filter system versus traditional density centrifugation method.
abstract: BACKGROUND
  We created the first tissue-engineered vascular graft (TEVG) to be successfully used in humans. The TEVG is made by seeding autologous bone marrow-derived mononuclear cells (BM-MNCs) onto a biodegradable tubular scaffold fabricated from polyglycolic-acid mesh coated with a 50:50 copolymer of poly-L-lactide and-ɛ-caprolactone. In the initial clinical study, the BM-MNCs were isolated using a Ficoll density centrifugation method. Use of this cell isolation technique is problematic in that it is performed using an open system and therefore is susceptible to contamination. As a first step toward creating a closed system for assembling a TEVG, we evaluated the use of a filter-based method for isolating BM-MNCs and compared it to density centrifugation in Ficoll.
  
  
  METHODS
  BM-MNCs were isolated from human BM using density centrifugation in Ficoll or a filter-based method. BM-MNCs were seeded onto biodegradable tubular scaffold and incubated for 24 h before implantation. The TEVG were implanted as inferior vena cava interposition grafts in SCID/bg mice (n=24) using microsurgical technique. Grafts were followed with ultrasonography and computed tomography-angiography. Ten weeks after implantation the TEVG were explanted and examined using histology and immunohistochemistry.
  
  
  RESULTS
  Both methods isolated similar number of cells (Ficoll: 8.5±6.6×10(6)/mL, Filter: 6.6±3.5×10(6)/mL; p=0.686) with similar viability as assayed using fluorescence-activated cell sorting (FACS) (Ficoll: 97.0%±1.5%, Filter: 95.9%±3.0%; p=0.339). FACS analysis demonstrated that the fraction of lymphocytes and monocytes to total cells was lower in the filter group (CD4 in Ficoll: 8.9%±1.1%, CD4 in Filter: 3.5%±0.8%; p=0.002, CD8 in Ficoll: 9.4%±2.1%, CD8 in Filter: 3.9%±1.4%; p=0.021, Monocyte in Ficoll: 6.9%±1.0%, Monocyte in Filter: 2.7%±1.0%; p=0.008), consistent with granulocyte contamination (Ficoll: 46.6±2.7×10(6)/mL, Filter: 58.1±5.2×10(6)/mL; p<0.001). The ratio of stem cells to BM-MNCs was comparable between groups. There were no statistically significant differences with regard to TEVG patency and morphology between groups. Both methods of cell isolation produced neovessels with similar histology.
  
  
  CONCLUSIONS
  Filter-based BM-MNC isolation is comparable to BM-MNC isolation using density centrifugation in Ficoll for TEVG assembly. The filter-based cell isolation technique has the added advantage of the potential to create a closed disposable system.
authors: Interdepartmental Program in Vascular Biology and Therapeutics, Yale University School of Medicine, New Haven, Connecticut 06510, USA.
authors: Narutoshi
authors: N
authors: Hibino
authors: Ani
authors: A
authors: Nalbandian
authors: Lesley
authors: L
authors: Devine
authors: Rajendra Sawh
authors: RS
authors: Martinez
authors: Edward
authors: E
authors: McGillicuddy
authors: Tai
authors: T
authors: Yi
authors: Safa
authors: S
authors: Karandish
authors: Girolamo A
authors: GA
authors: Ortolano
authors: Toshiharu
authors: T
authors: Shin'oka
authors: Edward
authors: E
authors: Snyder
authors: Christopher K
authors: CK
authors: Breuer
references: J Immunol Methods. 2005 Dec 20;307(1-2):150-66
references: 16325197
references: J Immunol Methods. 2001 Jun 1;252(1-2):93-104
references: 11334969
references: J Thorac Cardiovasc Surg. 2005 May;129(5):1064-70
references: 15867781
references: Tissue Eng. 2006 Nov;12(11):3075-83
references: 17518623
references: Ann Surg. 2008 Sep;248(3):370-7
references: 18791357
references: Eur Heart J. 2007 Mar;28(6):766-72
references: 17298974
references: J Thorac Cardiovasc Surg. 2005 Jun;129(6):1330-8
references: 15942574
references: N Engl J Med. 2006 Sep 21;355(12):1210-21
references: 16990384
references: Transfusion. 2005 Jan;45(1):21-5
references: 15647014
references: Regen Med. 2009 Sep;4(5):689-96
references: 19761394
references: J Pediatr Surg. 2006 Apr;41(4):787-91
references: 16567194
references: Biomaterials. 2008 Apr;29(10):1454-63
references: 18164056
references: Transfusion. 2006 Jan;46(1):118-25
references: 16398740
references: N Engl J Med. 2001 Feb 15;344(7):532-3
references: 11221621
references: Crit Care. 2004;8 Suppl 2:S27-30
references: 15196319
references: N Engl J Med. 2006 Sep 21;355(12):1199-209
references: 16990383
references: Can J Anaesth. 2004 May;51(5):417-24
references: 15128625